GA121020
Fmoc-Ser(Neu5Acα(2-3)Galβ(1-3)GalNAc)-OH (Peracetate, Benzyl Ester)
Tumor-Associated Carbohydrate Antigen (TACA). STF-antigen (also ST) is a sialylated form of the truncated O-glycosylated core determinant TF (also T) with structure: Neu5Acα2-3Galβ1-3GalNAcα-O-Ser/Thr. STF results from an early sialylation of the TF antigen due to overexpression of the enzyme α2,3sialylT and/or disruption of further glycan elongation processes. STF is negligibly expressed in healthy tissues but overexpressed in human carcinomas . As such, STF is implicated in tumour cell organotropic metastasis. Targeting immune responses to truncated variants of O-glycan chains expressed by tumour cells represents a promising approach for the development of antigen-specific therapeutic vaccines against cancers, and accumulated evidence has rendered STF a prime target for cancer immunotherapy.
Inquire for price
- For research and development use only
-
Other Names
STF Epitope (Serine); STF Antigen (Serine); ST Antigen; Sialyl-T Antigen; Fmoc-L-Ser(Neu5Acα(2-3)Galβ(1-3)GalNAc)-OH (Peracetate, Benzyl Ester); Fmoc-Ser(α-L-Neu5Ac(Ac)4-(2-3)-β-D-Gal(Ac)3-(1-3)-α-D-GalNAc(Ac)2)-OH
-
Technical Data
CAS #: N/A
Formula: C62H77N3O32
Molecular Weight: 1376.28
Purity: >90% (HPLC)
-
Storage & Shipping
Shipping requirement: Dry Ice
Storage conditions: -20°C